Hemoperfusion for the treatment of poisoning: Technology, determinants of poison clearance, and application in clinical practice

Seminars in Dialysis

Volumn 27, Issue 4, 2014, Pages 350-361

  Ghannoum, Marc ^a   Bouchard, Josée ^b   Nolin, Thomas D ^c   Ouellet, Georges ^d   Roberts, Darren M ^e  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

POISON;

ANIMAL; BLOOD; DETOXIFICATION; HEMOPERFUSION; HUMAN; INTOXICATION; PROCEDURES; THERAPY;

ANIMALS; HEMOPERFUSION; HUMANS; POISONING; POISONS; SORPTION DETOXIFICATION;

EID: 84904043637     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12246     Document Type: Article

References (181)

1. Muirhead EE, Reid AF: A resin artificial kidney. J Lab Clin Med 33:841-844, 1948
2. Pallotta AJ, Koppanyi T: The use of ion exchange resins in the treatment of phenobarbital intoxication in dogs. J Pharmacol Exp Ther 128:318-327, 1960
3. Schreiner GE: The role of hemodialysis (artificial kidney) in acute poisoning. AMA Arch Intern Med 102:896-913, 1958
4. Ehlers SM, Zaske DE, Sawchuk RJ: Massive theophylline overdose. Rapid elimination by charcoal hemoperfusion. JAMA 240:474-475, 1978
5. Vale JA, Crome P, Volans GN, Widdop B, Goulding R: The treatment of paraquat poisoning using oral sorbents and charcoal haemoperfusion. Acta Pharmacol Toxicol (Copenh) 41(Suppl. 2):109-117, 1977
6. Rosenbaum JL, Kramer MS, Raja R, Boreyko C: Resin hemoperfusion: a new treatment for acute drug intoxication. N Engl J Med 284:874-877, 1971
7. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186-1192, 1988
8. Winchester JF, Gelfand MC, Knepshield JH, Schreiner GE: Present and future uses of hemoperfusion with sorbents. Artif Organs 2:353-358, 1978
9. Dmitriev AA, Ivanov OL, Ovcharov AA, Fomin AS, Petrova GN: Experience using hemosorption therapy in allergic cutaneous vasculitis. Vestn Dermatol Venerol 9:19-22, 1981
10. Dmitriev AA, Ivanova MM, Ivanov OL, Khapilova VI: Effect of hemosorption on the course of autoimmune diseases with predominant involvement of the skin. Klin Med (Mosk) 60:93-97, 1982
11. Mardini J, Lavergne V, Roberts D, Ghannoum M: Case reports of extracorporeal treatments in poisoning: historical trends. Semin Dial, this issue, 2014
12. Shannon MW: Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 4:674-678, 1997
13. Maslov OG, Brusin KM, Kochmashev VF, Sentsov VG: Comparative evaluation of methods of extracorporeal detoxification in acute carbamazepine poisoning. Clinical toxicology 12:1169-1179, 2011
14. Woo OF, Pond SM, Benowitz NL, Olson KR: Benefit of hemoperfusion in acute theophylline intoxication. J Toxicol Clin Toxicol 22:411-424, 1984
15. Gleeson GH, Nicotero JR, Duffy FC, Kennedy FB, Ticzon AR: Resin hemoperfusion in acute digoxin intoxication. JAMA 240:2731, 1978
16. Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS: Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 74:1327-1334, 2008
17. Shalkham AS, Kirrane BM, Hoffman RS, Goldfarb DS, Nelson LS: The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 48:239-241, 2006
18. Roberts DM, Buckley NA: Pharmacokinetic considerations in clinical toxicology: clinical applications. Clin Pharmacokinet 46:897-939, 2007
19. Lavergne V, Nolin TD, Hoffman RS, Robert D, Gosselin S, Goldfarb DS, Kielstein JT, Mactier R, MacLaren R, Mowry JB, Bunchman TE, Juurlink D, Megarbane B, Anseeuw K, Winchester JF, Dargan PI, Liu KD, Hoegberg LC, Li Y, Calello D, Burdmann EA, Yates C, Laliberte M, Decker BS, Mello-Da-Silva CA, Lavonas E, Ghannoum M: The EXTRIP (Extracorporeal Treatments In Poisoning) workgroup: Guideline methodology. Clin Toxicol 50:403-413, 2012
20. Okonek S, Reininghaus I, Setyadharma H, Gaudron P: An economical hemoperfusion system to determine in vitro clearances of various poisons with different adsorbents. Arch Toxicol 46:215-220, 1980
21. Kawasaki CI, Nishi R, Uekihara S, Hayano S, Kragh-Hansen U, Otagiri M: How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases? Clin Toxicol (Phila) 43:95-99, 2005
22. Okonek S: Intoxication with pyrazolones. Br J Clin Pharmacol 10(Suppl. 2):385S-390S, 1980
23. Zaccara G, Messori A, Moroni F: Clinical pharmacokinetics of valproic acid-1988. Clin Pharmacokinet 15:367-389, 1988
24. Needs CJ, Brooks PM: Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10:164-177, 1985
25. Roberts DM, Dawson AH, Senarathna L, Mohamed F, Cheng R, Eaglesham G, Buckley NA: Toxicokinetics, including saturable protein binding, of 4-chloro-2-methyl phenoxyacetic acid (MCPA) in patients with acute poisoning. Toxicol Lett 201:270-276, 2011
26. Chang TM: Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int Suppl 7:387-392, 1975
27. Tessore V, Luboz MP, Denti E: Use of uncoated activated carbon hemoperfusion in acute poisoning: in vitro studies. Contrib Nephrol 29:65-75, 1982
28. Denti E, Luboz MP, Tessore V: Adsorption characteristics of cellulose acetate coated charcoals. J Biomed Mater Res 9:143-150, 1975
29. Cohan SL, Winchester JF, Gelfand MC: Treatment of intoxication with charcoal hemadsorption. Drug Metab Rev 13:681-693, 1982
30. Laurent D, Guenzet J, Bourin M: Theophylline: a haemoperfusion modelisation. Methods Find Exp Clin Pharmacol 7:253-258, 1985
31. Ambruss CM, Karakousis CP, Stadler A, Stadler I, Ambrus JL Jr, Anthone S, Ambrus JL: Reducing toxicity of cisplatin in cancer chemotherapy by extracorporeal removal of excess cisplatin. J Med 33:119-127, 2002
32. Rawer P, Leber HW: Selective hemoperfusion. Med Welt 29:1449-1452, 1978
33. Widdop B, Medd RK, Braithwaite RA, Rees AJ, Goulding R: Experimental drug intoxication: treatment with charcoal haemoperfusion. Arch Toxicol 34:27-36, 1975
34. Whalen JE, Richards CJ, Ambre J: Inadequate removal of methanol and formate using the sorbent based regeneration hemodialysis delivery system. Clin Nephrol 11:318-321, 1979
35. Winchester JF, Edwards RO, Tilstone WJ, Woodcock BG: Activated charcoal hemoperfusion and experimental acetaminophen poisoning. Toxicol Appl Pharmacol 31:120-127, 1975
36. Yatzidis H: A convenient hemoperfusion micro-apparatus over charcoal for the treatment of exogenous and endogenous intoxications. Its use as an artificial kidney. Proc Eur Dial Transplant Assoc 1:83, 1964
37. Chang TM: Hemoperfusion in 1981. Contrib Nephrol 29:11-22, 1982
38. Hill JB, Palaia FL, McAdams JL, Palmer PJ, Skinner JT, Maret SM: The rationale for fixed-bed charcoal in hemoperfusion. Kidney Int Suppl 7: S328-S332, 1976
39. Chang TM, Gonda A, Dirks JH, Coffey JF, Lee-Burns T: ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure. Trans Am Soc Artif Intern Organs 18: 465-472; 484, 1972
40. Tobin M, Cerra F, Steinbach J, Mookerjee B: Hemoperfusion in digitalis intoxication: a comparative study of coated versus uncoated charcoal. Trans Am Soc Artif Intern Organs 23:730-731, 1977
41. Falkenhagen D, Gottschall S, Esther G, Courtney JM, Klinkmann H: In vitro assessment of charcoal and resin hemoadsorbents. Contrib Nephrol 29:23-33, 1982
42. Asbach HW, Holz F, Mohring K, Schuler HW: Lipid hemodialysis versus charcoal hemoperfusion in imipramine poisoning. Clin Toxicol 11:211-219, 1977
43. Holt DW, Helliwell M, O'Keeffe B, Hayler AM, Marshall CB, Cook G: Successful management of serious disopyramide poisoning. Postgrad Med J 56:256-260, 1980
44. Winchester JF, Rahman A, Tilstone WJ, Bregman H, Mortensen LM, Gelfand MC, Schein PS, Schreiner GE: Will hemoperfusion be useful for cancer chemotherapeutic drug removal? Clin Toxicol 17:557-569, 1980
45. Hayler AM, Medd RK, Holt DW, O'Keeffe BD: Experimental disopyramide poisoning: treatment by cardiovascular support and with charcoal hemoperfusion. J Pharmacol Exp Ther 211:491-495, 1979
46. Hayler AM, Medd RK, Holt DW, O'Keefe BD: Treatment of disopyramide overdosage. Vet Hum Toxicol 21(Suppl.):93-95, 1979
47. Raper S, Crome P, Vale A, Helliwell M, Widdop B: Experience with activated carbon-bead haemoperfusion columns in the treatment of severe drug intoxication. A preliminary report. Arch Toxicol 49:303-310, 1982
48. Cooney DO, Infantolino W, Kane R: Comparative studies of hemoperfusion devices. I. In vitro clearance characteristics. Biomater Med Devices Artif Organs 6:199-213, 1978
49. Ton HY, Hughes RD, Silk DB, Williams R: Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part I: adsorption studies. Artif Organs 3:20-22, 1979
50. Rosenbaum JL, Barber KG, Raja RM, Kramer MS, Fernandes MV: The effect of human serum albumin coating on Amberlite XAD-4 resin hemoperfusion. Trans Am Soc Artif Intern Organs 28:333-337, 1982
51. Gundermann KJ, Lie TS: Possibilities to avoid adsorption of physiological substances during charcoal hemoperfusion (author's transl). Res Exp Med (Berl) 173:105-111, 1978
52. Hughes RD, Ton HY, Langley PG, Silk DB, Williams R: The use of an in vitro haemoperfusion circuit to evaluate the blood compatibility of albumin-coated Amberlite XAD-7 resin. Int J Artif Organs 1:129-134, 1978
53. Chang TM: Removal of endogenous and exogenous toxins by a microencapsulated absorbent. Can J Physiol Pharmacol 47:1043-1045, 1969
54. Gundermann KJ, Lie TS: Problems of competition in charcoal hemoperfusion for the treatment of intoxications. Artif Organs 3:346-349, 1979
55. Rosenbaum JL, Winsten S, Kramuer MS, Moros J, Raja R: Resin hemoperfusion in the treatment of drug intoxication. ASAIO Trans 16:134-140, 1970
56. Maini R: Haemoperfusion over ion exchange resins and polymeric adsorbents. Int J Artif Organs 1:196-201, 1978
57. Derzsiova K, Mydlik M, Petrikova V: Hemoperfusion study with carbamazepine in vitro. Int J Artif Organs 22:730-733, 1999
58. Derzsiova K, Mydlik M, Petrikova V, Molcanyiova A: Hemoperfusion of amitriptyline and nortriptylin - An in vitro study [Czech]. Aktuality v Nefrologii 11(1):6-10, 2005
59. Mydlik M, Derzsiova K, Klan J, Zima T: Hemoperfusion with alpha-amanitin: an in vitro study. Int J Artif Organs 20:105-107, 1997
60. Sideman S, Chang TM: Hemoperfusion: state of the art and future requirements. Artif Organs 4:70-75, 1980
61. Sideman S, Lotan N, Tabak A, Manor D, Mor L, Taitelman U, Brook J, Tzipiniuk A: Tailor-made agarose-based reactive beads for hemoperfusion and plasma perfusion. Appl Biochem Biotechnol 10:167-182, 1984
62. Sideman S, Taitelman U, Tabak A: Paraquat removal by hemoperfusion utilizing a beaded composite sorbent. Vet Hum Toxicol 24 (Suppl.): 43-47+177, 1982
63. Tabak A, Lotan N, Sideman S, Taitelman U: Novel composite sorbent beads for paraquat removal by hemoperfusion. Artif Organs 7:176-185, 1983
64. De Groot G, Maes RA, Van Heijst AN: A toxicological evaluation of different adsorbents in hemoperfusion. Clin Toxicol 18:1199-1211, 1981
65. Okonek S, Weilemann LS, Majdandzic J, Setyadharma H, Reinecke HJ, Baldamus CA, Lohmann J, Bonzel KE, Thon T: Successful treatment of paraquat poisoning: activated charcoal per os and "continuous hemoperfusion". J Toxicol Clin Toxicol 19:807-819, 1982
66. Gal G: Haemodialysis/haemoperfusion in paraquat poisoning. Int J Artif Organs 13:778, 1990
67. Risler T, Arnold G, Grabensee B: Is hemoperfusion effective in the treatment of digoxin intoxication? (author's transl) [German] Z Kardiol 68:313-319, 1979
68. Mathieu D, Gosselin B, Nolf M, Dupuis B, Marchandise X, Boidein M, Wattel F: Massive digitoxin intoxication. Treatment of Amberlite XAD 4 resin hemoperfusion. J Toxicol Clin Toxicol 19:931-950, 1982
69. Hampel G, Widdop B, Goulding R: Adsorptive capacities of hemoperfusion devices in clinical use. Artif Organs 2:363-366, 1978
70. Leblanc M, Fedak S, Mokris G, Paganini EP: Blood recirculation in temporary central catheters for acute hemodialysis. Clin Nephrol 45:315-319, 1996
71. Lee JC, Park CY, Choi SW, Kim JC, Lim KM, Kim K, Jung SK, Kwak YH, Shin SD, Jo IJ, Suh GJ, Min BG: Comparison of a pulsatile blood pump and a peristaltic roller pump during hemoperfusion treatment in a canine model of paraquat poisoning. Artif Organs 32:541-546, 2008
72. Suh GJ, Lee CC, Jo IJ, Shin SD, Lee JC, Min BG, Singer AJ: Hemoperfusion using dual pulsatile pump in paraquat poisoning. Am J Emerg Med 26:641-648, 2008
73. Butte W, Meyer GJ, Vollnberg W: Detoxication methods for bromureide poisoning. Comparison of haemodialysis, haemofiltration and haemoperfusion on bastard dogs. Arch Toxicol 41:61-67, 1978
74. Espinosa-Melendez E, Chang TM: ACAC (albumin-collodion coated activated charcoal) hemoperfusion: in-vitro removal and clearance of theophylline. J Dial 4:21-29, 1980
75. Tabei K, Asano Y, Hosoda S: Efficacy of charcoal hemoperfusion in paraquat poisoning. Artif Organs 6:37-42, 1982
76. Yoshida K, Asano Y, Nakajima I: The treatment of 10 cases of paraquat poisoning using charcoal haemoperfusion. Jpn J Nephrol 22:1001-1012, 1980
77. Derzsiova K, Mydlik M, Petrikova V, Vzentekova T, Molcanyiova A: Hemoperfusion of theophylline. An in vitro study [Slovak]. Cas Lek Cesk 130(1):11-14, 1991
78. Monhart V, Svec F, Tlustakova M, Kalal J: Possible uses of Czechoslovak-made resin sorbents for haemoperfusion in cases of intoxication with psychopharmacological agents. Cas Lek Cesk 121:783-786, 1982
79. Rahman MH, Haqqie SS, McGoldrick MD: Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion. Hemodial Int 10:256-259, 2006
80. Gosselin B, Mathieu D, Chopin C, Wattel F, Dupuis B, Boidein M: Massive digitalis poisoning. Treatment by hemoperfusion on Amberlite XAD-4 resin. Rev Med Interne 2:313-323, 1981
81. Dehua G, Daxi J, Honglang X, Bin X, Yun L, Leishi L: Sequential hemoperfusion and continuous venovenous hemofiltration in treatment of severe tetramine poisoning. Blood Purif 24:524-530, 2006
82. Bentley C, Kjellstrand CM: The treatment of severe drug intoxication with charcoal hemoperfusion in series with hemodialysis. J Dial 3:337-348, 1979
83. Wright N, Bhamjee A: Gentamicin extraction from an anuric patient by combined haemodialysis and charcoal haemoperfusion. Postgrad Med J 56:140-141, 1980
84. Lee CJ, Hsu HW, Chang YL: Performance characteristics of combined haemodialysis/haemoperfusion system for removal of blood toxins. Med Eng Phys 19:658-667, 1997
85. Pond S, Rosenberg J, Benowitz NL, Takki S: Pharmacokinetics of haemoperfusion for drug overdose. Clin Pharmacokinet 4:329-354, 1979
86. Rosenbaum JL, Kramer MS, Raja RM: Amberlite hemoperfusion in the treatment of acute drug intoxication. Int J Artif Organs 2:316-318, 1979
87. Hoy W, Schwab G, Freeman RB: Clearance of meprobamate by hemoperfusion over columns of charcoal and Amberlite resin. Studies in a patient. Artif Organs 2:395-397, 1978
88. Balikova M, Monhart V, Tlustakova M: Scorption efficiency of Czechoslovak haemoperfusion columns 'Hemasorb' in toxicological indications [Czech]. Vnitr Lek 33(9):772-776, 1987
89. Trotsevich VA, Kurashov OV: Comparative characteristics of the variants of vascular approach during performing hemosorption in patients with acute poisoning. Klin Khir 3:39-40, 1991
90. Parienti JJ, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marque S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P; Members of the Cathedia Study G: Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299:2413-2422, 2008
91. Rabindranath KS, Kumar E, Shail R, Vaux EC: Ultrasound use for the placement of haemodialysis catheters. Cochrane Database Syst Rev:CD005279, 2011
92. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN: Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543-2545, 2000
93. Mamdani B, Dunea G, Siemsen AW: Long-term hemoperfusion with coated activated charcoal. Clin Toxicol 17:543-546, 1980
94. Mydlik M, Bucek J, Derzsiova K, Jarcuska J, Takac M: Influence of charcoal haemoperfusion on platelet count in acute poisoning and during regular dialysis treatment. Int Urol Nephrol 13:387-389, 1981
95. Stein G, Sperschneider H, Boerner A: Influence of hemoperfusion with XAD-4 resin on the concentration of biologic constituents in the blood. Int J Artif Organs 5(2):105-109, 1982
96. Haapanen EJ: Hemoperfusion in acute intoxication. Clinical experience with 48 cases. Acta Med Scand Suppl 668:76-81, 1982
97. Koffler A, Bernstein M, LaSette A, Massry SG: Fixed-bed charcoal hemoperfusion. Treatment of drug overdose. Arch Intern Med 138:1691-1694, 1978
98. Hennemann H, Richter IE, Brunswig D, Rockel A, Kult J, Gattenlohner W, Heidland A: The pros and cons of haemoperfusion (author's transl). Klin Wochenschr 55:533-537, 1977
99. Mydlik M, Takac M, Derzsiova K, Ahlers I, Jarcuska J, Kunayova K, Kochan I, Simkova T: Use of hemoperfusion over activated charcoal in acute poisoning [Slovak]. Vnitr Lek 25(6):567-577, 1979
100. Wronski R, Bruhn HD, Albert JP, Niedermayer W: Side-effects on the coagulation system by hemoperfusion [German]. Medizinische Welt 32(28):1127-1129, 1981
101. Lohmann J, Pott G, Voss B, Gerlach U: Drug intoxication: influence of hemoperfusion on human plasma fibronectin. Klin Wochenschr 61:369-372, 1983
102. Rommes JH, Sangster B, Gmelig Meyling FH, Daha MR, van Heijst AN: The influence of haemoperfusion on white cells, immunoglobulin concentrations and the complement system in the treatment of intoxications. Arch Toxicol 52:149-156, 1983
103. Chishiro T, Moriguchi T, Tatsumi M, Kitazawa Y, Takeyama N, Tanaka T: Clinical evaluation of the effects of direct hemoperfusion on amino acid profiles. Vet Hum Toxicol 35(1):25-28, 1993
104. Li PK, Lai KN: Active therapeutic approaches to drug intoxication. Adverse Drug React Acute Poisoning Rev 7:55-73, 1988
105. Maslov OG, Brusin KM, Kochmashev VF, Sentsov VG: Comparative evaluation of methods of extracorporeal detoxification in acute carbamazepine poisoning [Russian]. Clin Toxicol 12:1169-1179, 2011
106. Chang TM, Chirito E, Barre P, Cole C, Lister C, Resurreccion E: Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia. Artif Organs 3:127-131, 1979
107. Cohn HE, Weiss AJ, Clark JE, Nealon TF Jr: An ion-exchange resin artificial kidney. Surg Forum 11:15-17, 1960
108. Gosselin S: Systematic review: evidence for extracorporeal treatments in paraquat poisoning. Proceedings of The ACMT Conference, Hong Kong, 2012
109. Gil HW, Kim SJ, Yang JO, Lee EY, Hong SY: Clinical outcome of hemoperfusion in poisoned patients. Blood Purif 30:84-88, 2010
110. Ghannoum M, Troyanov S, Ayoub P, Lavergne V, Hewlett T: Successful hemodialysis in a phenytoin overdose: case report and review of the literature. Clin Nephrol 74:59-64, 2010
111. Ozhasenekler A, Gokhan S, Guloglu C, Orak M, Ustundag M: Benefit of hemodialysis in carbamazepine intoxications with neurological complications. Eur Rev Med Pharmacol Sci 16(Suppl. 1):43-47, 2012
112. Azak A, Kocak G, Huddam B, Duranay M: Is conventional hemodialysis enough to manage carbamazepine intoxication? Blood Purif 33:225-226, 2012
113. de Wolff FA, Smit ND: Analysis of haemoperfusion columns for evaluation of treatment of phenobarbital overdosage. Arch Toxicol 43:233-235, 1980
114. De Wolff FA, Smit ND, Grunewald EJ, Schicht IM: Evaluation of haemoperfusion by column analysis. Dev Toxicol Environ Sci 8:405-409, 1980
115. Takeda K, Nakamoto M, Yasunaga C, Nishihara G, Matsuo K, Urabe M, Kitamura M, Nozoe T: Acute hemorrhagic gastritis associated with acetazolamide intoxication in a patient with chronic renal failure. Clin Nephrol 48:266-268, 1997
116. Monhart V, Balikova M, Tlustakova M: Sorption effectiveness of Czech haemoperfusion sorbents for amatoxins [Czech]. Cas Lek Cesk 133(6):181-183, 1994
117. Rockel A, Schmid G, Rupp P, Kult J, Hennemann H, Heidland A: Haemoperfusion with activated charcoal and ion exchanger in phalloidin intoxicated rats (author's transl). Dtsch Med Wochenschr 101:418-420, 1976
118. Erguven M, Caki S, Deveci M: Cases of mushroom poisoning: Evaluation of 28 cases [Turkish]. Cocuk Sagligi ve Hastaliklari Dergisi 47(4):249-253, 2004
119. Cooney DO, Kane RP: The thin-film adsorber hemoperfusion device: development and evaluation of clearance characteristics. Artif Organs 6:151-162, 1982
120. Medd RK, Widdop B, Braithwaite RA, Rees AJ, Goulding R: Comparison of haemoperfusion and haemodialysis in the therapy of barbiturate intoxication in dogs. Arch Toxikol 31:163-174, 1973
121. Morikawa N, Mori K, Fujii I, Takeyama M: Pharmacokinetic study in acute antiepileptic intoxication treated with hemodialysis and hemoperfusion [Japanese]. Jpn J Clin Pharmacol Ther 23(2):469-474, 1992
122. Lu ZN, Cai ZH, Wu ZG: Resin hemoperfusion for acute pentobarbital intoxication in rats and rabbits [Chinese]. Acta Pharmacol Sin 5(4):281-285, 1984
123. Verpooten GA, Heyndrickx A, Zachee P, De Broe ME: Comparison of hemoperfusion and hemodialysis clearances during combined and prolonged treatment of severely poisoned patients. Dev Toxicol Environ Sci 8:411-414, 1980
124. Klehr HU, Goenechea S, Eichelbaum M: Effect of extracorporeal hemoperfusion on the elimination of carbromal in carbromal poisoning. Verh Dtsch Ges Inn Med 83:1612-1614, 1977
125. Kopelman R, Miller S, Kelly R, Sunshine I: Camphor intoxication treated by resin hemoperfusion. JAMA 241:727-728, 1979
126. Koppel C, Tenczer J, Schirop T, Ibe K: Camphor poisoning. Abuse of camphor as a stimulant. Arch Toxicol 51(1):101-106, 1982
127. Leber HW, Geissler RH, Post D: Carbromal intoxication-hemodialysis or hemoperfusion? Acta Pharmacol Toxicol (Copenh) 41(Suppl. 2):78-84, 1977
128. Pizzella KM, Moore MC, Schultz RW, Walshe J, Schentag JJ: Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion. Ther Drug Monit 2:273-281, 1980
129. Endre ZH, Charlesworth JA, Macdonald GJ, Woodbridge L: Successful treatment of acute dapsone intoxication using charcoal hemoperfusion. Aust N Z J Med 13:509-512, 1983
130. Okonek S: Hemoperfusion in toxicology. Basic considerations of its effectiveness. Clin Toxicol 18:1185-1198, 1981
131. Gilfrich HJ, Okonek S, Manns M, Schuster CJ: Digoxin and digitoxin elimination in man by charcoal hemoperfusion. Klin Wochenschr 56:1179-1183, 1978
132. Okonek S, Gilfrich HJ: In vitro and in vivo trials carried out to determine the efficacy of hemoperfusion in severe digitalis-intoxication. Vet Hum Toxicol 21(Suppl):15-17, 1979
133. Gundert-Remy U, Goetz R, Seitz H, Cygan P: Effectivity of hemoperfusion in patients with digoxin overdosage. Naunyn-Schmiedeberg's Arch Pharmacol 316(Suppl.):323, 1981
134. Tsuruoka S, Osono E, Nishiki K, Kawaguchi A, Arai T, Furuyoshi S, Saito T, Takata S, Sugimoto K, Kurihara S, Fujimura A: Removal of digoxin by column for specific adsorption of beta(2)-microglobulin: a potential use for digoxin intoxication. Clin Pharmacol Ther 69:422-430, 2001
135. Koppel C, Forycki Z, Ibe K: Hemoperfusion in severe dimethoate poisoning. Intensive Care Med 12:110-112, 1986
136. Nagler J, Braeckman RA, Willems JL, Verpooten GA, De Broe ME: Combined hemoperfusion-hemodialysis in organophosphate poisoning. J Appl Toxicol 1:199-201, 1981
137. Okonek S, Tonnis J, Baldamus CA, Hofmann A: Hemoperfusion versus hemodialysis in the management of patients severely poisoned by organophosphorus insecticides and bipyridyl herbicides. Artif Organs 3:341-345, 1979
138. Trafford JA, Jones RH, Evans R, Sharp P, Sharpstone P, Cook J: Haemoperfusion with R-004 Amberlite resin for treating acute poisoning. Br Med J 2:1453-1456, 1977
139. Konigshausen T, Altrogge G, Hein D, Grabensee B, Putter D: Hemodialysis and hemoperfusion in the treatment of most severe INH-poisoning. Vet Hum Toxicol 21(Suppl.):12-15, 1979
140. Krakamp B, Aboudan F, Heesen D: Haemoperfusion in the treatment of acute isoniazid poisoning (author's transl). Prax Klin Pneumol 36:14-16, 1982
141. Giardino R, Fini M, Giavaresi G, Spighi M, Faenza S, Orlandi M, Florio ML: In vitro and ex vivo evaluation of Methotrexate removal by different sorbents Haemoperfusion. Biomater Artif Cells Immobilization Biotechnol 21(4):447-454, 1993
142. Gibson TP, Reich SD, Krumlovsky FA, Ivanovich P, Gonczy C: Hemoperfusion for methotrexate removal. Clin Pharmacol Ther 23:351-355, 1978
143. Frappaz D, Bouffet E, Cochat P, Laville M, Finaz de Vilaine J, Philip T, Biron P, Zanettini MC, Latour JF, Gueho A, Brunat Mentigny M: Hemoperfusion on charcoal and hemodialysis in acute poisoning caused by methotrexate. Presse Med 17:1209-1213, 1988
144. Mastrangelo F, Lopez T, Rizzelli S: Hemodialysis and hemoperfusion in the treatment of Paraquat and Diquat poisoning [Italian]. Minerva Nefrol 26(3):399-403, 1979
145. Maini R: Removal of paraquat from blood by haemoperfusion over sorbent materials. Br Med J 3:281-282, 1975
146. Okonek S: New ideas on treatment of paraquat poisoning [German]. Therapiewoche 34(27):4166-4178, 1984
147. Talbot AR: A comparison of hemoperfusion columns for paraquat. Vet Hum Toxicol 31:131-135, 1989
148. Van de Vyver FL, Giuliano RA, Paulus GJ, Verpooten GA, Franke JP, De Zeeuw RA, Van Gaal LF, De Broe ME: Hemoperfusion-hemodialysis ineffective for paraquat removal in life-threatening poisoning? J Toxicol Clin Toxicol 23:117-131, 1985
149. Solfrank G, Mathes GV, Clarmann M, Beyer KH: Haemoperfusion through activated charcoal in paraquat intoxication. Acta Pharmacol Toxicol (Copenh) 41(Suppl. 2):91-101, 1977
150. Hong SY, Yang JO, Lee EY, Kim SH: Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo. Toxicol Ind Health 19:17-23, 2003
151. Schirop T, Barckow D, Becker H: Clinical aspects of pentenamid-intoxication and results of hemodialysis and hemoperfusion [German]. Intensivmedizin 17(2):53-56, 1980
152. Tonnesmann U, Koppel C, Schirop T: Clinical aspect and therapy of a severe exogenic intoxication with pine oil [German]. Intensivmedizin 19(6):270-274, 1982
153. Bauer LA, Raisys VA, Watts MT, Ballinger J: The pharmacokinetics of thiabendazole and its metabolites in an anephric patient undergoing hemodialysis and hemoperfusion. J Clin Pharmacol 22:276-280, 1982
154. Pall H: The use of haemocol hemoperfusion [German]. Wien Klin Wochenschr Suppl 89:1-12, 1978
155. Franssen EJ, van Essen GG, Portman AT, de Jong J, Go G, Stegeman CA, Uges DR: Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 21:289-292, 1999
156. Sliwkiewicz K, Winnicka R, Rzepecki J, Kolacinski Z, Krakowiak A: Acute Intoxication with valproic acid, treated with hemodialysis/hemoperfusion in series - Case report (abstract). Clin Toxicol 48:248, 2010
157. Rosansky SJ: Verapamil toxicity-treatment with hemoperfusion. Ann Intern Med 114:340-341, 1991
158. Aarseth HP, Ganss R: Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers. Nephrol Dial Transplant 5:942-944, 1990
159. Chang TM, Barre P: Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis. Lancet 2:1051-1053, 1983
160. Bouchard NC, Malostovker I, Harbord N, Nelson LS, Feinfeld DA, Dubrow A, Hoffman RS, Winchester JF: Acute aluminum encephalopathy from alum bladder irrigation: aluminum extraction with high flux hemodialysis is superior to charcoal hemoperfusion [abstract]. Clin Toxicol (Phila) 43:677-678, 2005
161. Weiss LG, Danielson BG, Fellstrom B, Wikstrom B: Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency. Nephron 51:325-329, 1989
162. Tanaka J, Yamashita M, Yamamoto T: A comparative study of direct hemoperfusion and hemodialysis for the removal of glufosinate ammonium. J Toxicol Clin Toxicol 33:691-694, 1995
163. Majelyne W, De Clerck F, Demeter J, Heyndrickx A: Treatment evaluation of a severe methaqualone intoxication in man. Vet Hum Toxicol 21(Suppl.):201-204, 1979
164. Kleinbloesem CH, van Brummelen P, Woittiez AJ, Faber H, Breimer DD: Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion. Clin Pharmacokinet 11:316-322, 1986
165. Gibson TP, Matusik E, Nelson LD, Briggs WA: Artificial kidneys and clearance calculations. Clin Pharmacol Ther 20:720-726, 1976
166. Sentsov VG, Brusin KM, Meledin VY, Novikova OV, Urazaev TH: Comparison of charcoal hemoperfusion and hemodialysis in treatment of severe carbamazepine intoxications [abstract]. Clin Toxicol (Phila) 45:346, 2007
167. Tapolyai M, Campbell M, Dailey K, Udvari-Nagy S: Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning. Nephron 90:213-215, 2002
168. de Groot G, van Heijst AN, Maes RA: Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning. J Toxicol Clin Toxicol 22:349-362, 1984
169. De Schoenmakere G, De Waele J, Terryn W, Deweweire M, Verstraete A, Hoste E, Rottey S, Lameire N, Colardyn F: Phenytoin intoxication in critically ill patients. Am J Kidney Dis 45:189-192, 2005
170. Braden GL, Fitzgibbons JP, Germain MJ, Ledewitz HM: Hemoperfusion for treatment of N-acetylprocainamide intoxication. Ann Intern Med 105:64-65, 1986
171. Low CL, Phelps KR, Bailie GR: Relative efficacy of haemoperfusion, haemodialysis and CAPD in the removal of procainamide and NAPA in a patient with severe procainamide toxicity. Nephrol Dial Transplant 11:881-884, 1996
172. Rosansky SJ, Brady ME: Procainamide toxicity in a patient with acute renal failure. Am J Kidney Dis 7:502-506, 1986
173. Higgins RM, Hearing S, Goldsmith DJ, Keevil B, Venning MC, Ackrill P: Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis? Postgrad Med J 71:224-226, 1995
174. Davis E, Perez A, McKay C: A novel self-contained hemoperfusion device for the treatment of theophylline overdcose in a swine model [abstract]. Clin Toxicol (Phila) 41:695-696, 2003
175. Powell D, Pond SM, Allen TB, Portale AA: Hemoperfusion in a child who ingested diquat and died from pontine infarction and hemorrhage. J Toxicol Clin Toxicol 20:405-420, 1983
176. Fulde K, Bohler J, Keller E, Frahm AW: Efficiency of haemoperfusion materials at removing the fungal toxin orellanine from human plasma. Pharmazie 53(1):58-59, 1998
177. Hruby K, Lenz K, Druml W: Elimination of chlorfenvinphos by different hemoperfusion systems. Arch Toxicol 49(Suppl. 5):382-385, 1982
178. Berlinger WG, Spector R, Flanigan MJ, Johnson GF, Groh MR: Hemoperfusion for phenylbutazone poisoning. Ann Intern Med 96:334-335, 1982
179. Koppel C, Baudisch H, Beyer KH, Kloppel I, Schneider V: Fatal poisoning with selenium dioxide. J Toxicol Clin Toxicol 24:21-35, 1986
180. Sorken HL, Gunsalus E, Clark JE: Removal of sympathicomimetic amines during hemoperfusion across resin and charcoal columns. Trans Am Soc Artif Intern Organs 8:396-397, 1981
181. Koppel C, Baudisch H, Keller F: Methoxyethylmercury chloride poisoning: clinical findings and in vitro experiments. J Toxicol Clin Toxicol 19:391-400, 1982